vs
BALCHEM CORP（BCPC）与BILL Holdings, Inc.（BILL）财务数据对比。点击上方公司名可切换其他公司
BILL Holdings, Inc.的季度营收约是BALCHEM CORP的1.6倍（$414.7M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs -0.6%，领先15.5%），BILL Holdings, Inc.同比增速更快（14.4% vs 9.8%），过去两年BILL Holdings, Inc.的营收复合增速更高（13.3% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
BILL Holdings, Inc. 是总部位于美国加利福尼亚州圣何塞的企业，专注为美国小型企业提供自动化云原生财务运营软件。旗下Bill.com Connect是白标端到端支付自动化平台，可供金融机构接入其单点登录的线上企业银行生态中使用。
BCPC vs BILL — 直观对比
营收规模更大
BILL
是对方的1.6倍
$263.6M
营收增速更快
BILL
高出4.5%
9.8%
净利率更高
BCPC
高出15.5%
-0.6%
两年增速更快
BILL
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $414.7M |
| 净利润 | $39.2M | $-2.6M |
| 毛利率 | 35.6% | 79.8% |
| 营业利润率 | 19.8% | -4.4% |
| 净利率 | 14.9% | -0.6% |
| 营收同比 | 9.8% | 14.4% |
| 净利润同比 | 16.8% | -107.7% |
| 每股收益（稀释后） | $1.21 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCBILL
| Q4 25 | $263.6M | $414.7M | ||
| Q3 25 | $267.6M | $395.7M | ||
| Q2 25 | $255.5M | $383.3M | ||
| Q1 25 | $250.5M | $358.2M | ||
| Q4 24 | $240.0M | $362.6M | ||
| Q3 24 | $239.9M | $358.4M | ||
| Q2 24 | $234.1M | $343.7M | ||
| Q1 24 | $239.7M | $323.0M |
净利润BCPCBILL
| Q4 25 | $39.2M | $-2.6M | ||
| Q3 25 | $40.3M | $-3.0M | ||
| Q2 25 | $38.3M | $-7.1M | ||
| Q1 25 | $37.1M | $-11.6M | ||
| Q4 24 | $33.6M | $33.5M | ||
| Q3 24 | $33.8M | $8.9M | ||
| Q2 24 | $32.1M | $7.6M | ||
| Q1 24 | $29.0M | $31.8M |
毛利率BCPCBILL
| Q4 25 | 35.6% | 79.8% | ||
| Q3 25 | 35.7% | 80.5% | ||
| Q2 25 | 36.4% | 80.8% | ||
| Q1 25 | 35.2% | 81.2% | ||
| Q4 24 | 36.0% | 81.6% | ||
| Q3 24 | 35.6% | 82.0% | ||
| Q2 24 | 35.5% | 81.0% | ||
| Q1 24 | 34.0% | 83.0% |
营业利润率BCPCBILL
| Q4 25 | 19.8% | -4.4% | ||
| Q3 25 | 20.4% | -5.2% | ||
| Q2 25 | 20.1% | -5.8% | ||
| Q1 25 | 20.4% | -8.1% | ||
| Q4 24 | 19.8% | -6.0% | ||
| Q3 24 | 20.0% | -2.1% | ||
| Q2 24 | 19.6% | -6.5% | ||
| Q1 24 | 17.4% | -8.6% |
净利率BCPCBILL
| Q4 25 | 14.9% | -0.6% | ||
| Q3 25 | 15.1% | -0.7% | ||
| Q2 25 | 15.0% | -1.8% | ||
| Q1 25 | 14.8% | -3.2% | ||
| Q4 24 | 14.0% | 9.3% | ||
| Q3 24 | 14.1% | 2.5% | ||
| Q2 24 | 13.7% | 2.2% | ||
| Q1 24 | 12.1% | 9.8% |
每股收益（稀释后）BCPCBILL
| Q4 25 | $1.21 | $-0.03 | ||
| Q3 25 | $1.24 | $-0.03 | ||
| Q2 25 | $1.17 | $0.02 | ||
| Q1 25 | $1.13 | $-0.11 | ||
| Q4 24 | $1.03 | $-0.06 | ||
| Q3 24 | $1.03 | $0.08 | ||
| Q2 24 | $0.98 | $0.37 | ||
| Q1 24 | $0.89 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $1.1B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $1.3B | $3.8B |
| 总资产 | $1.7B | $10.1B |
| 负债/权益比越低杠杆越低 | — | 0.48× |
8季度趋势，按日历期对齐
现金及短期投资BCPCBILL
| Q4 25 | $74.6M | $1.1B | ||
| Q3 25 | $65.1M | $1.1B | ||
| Q2 25 | $65.4M | $1.0B | ||
| Q1 25 | $49.9M | $1.0B | ||
| Q4 24 | $49.5M | $1.6B | ||
| Q3 24 | $73.7M | $853.5M | ||
| Q2 24 | $63.7M | $985.9M | ||
| Q1 24 | $60.3M | $952.5M |
总债务BCPCBILL
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $914.8M | ||
| Q2 24 | — | $914.0M | ||
| Q1 24 | — | $1.1B |
股东权益BCPCBILL
| Q4 25 | $1.3B | $3.8B | ||
| Q3 25 | $1.3B | $3.9B | ||
| Q2 25 | $1.3B | $3.9B | ||
| Q1 25 | $1.2B | $3.9B | ||
| Q4 24 | $1.1B | $3.8B | ||
| Q3 24 | $1.2B | $4.0B | ||
| Q2 24 | $1.1B | $4.1B | ||
| Q1 24 | $1.1B | $4.1B |
总资产BCPCBILL
| Q4 25 | $1.7B | $10.1B | ||
| Q3 25 | $1.7B | $10.2B | ||
| Q2 25 | $1.7B | $10.1B | ||
| Q1 25 | $1.6B | $9.6B | ||
| Q4 24 | $1.6B | $9.7B | ||
| Q3 24 | $1.6B | $9.0B | ||
| Q2 24 | $1.6B | $9.2B | ||
| Q1 24 | $1.6B | $9.1B |
负债/权益比BCPCBILL
| Q4 25 | — | 0.48× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $105.3M |
| 自由现金流经营现金流 - 资本支出 | — | $103.8M |
| 自由现金流率自由现金流/营收 | — | 25.0% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $378.8M |
8季度趋势，按日历期对齐
经营现金流BCPCBILL
| Q4 25 | $67.3M | $105.3M | ||
| Q3 25 | $65.6M | $96.9M | ||
| Q2 25 | $47.3M | $83.8M | ||
| Q1 25 | $36.5M | $99.5M | ||
| Q4 24 | $52.3M | $78.7M | ||
| Q3 24 | $51.3M | $88.6M | ||
| Q2 24 | $45.0M | $78.6M | ||
| Q1 24 | $33.4M | $66.8M |
自由现金流BCPCBILL
| Q4 25 | — | $103.8M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $98.4M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | — | $88.6M | ||
| Q2 24 | — | $78.4M | ||
| Q1 24 | — | $66.8M |
自由现金流率BCPCBILL
| Q4 25 | — | 25.0% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 27.5% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 24.7% | ||
| Q2 24 | — | 22.8% | ||
| Q1 24 | — | 20.7% |
资本支出强度BCPCBILL
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
现金转化率BCPCBILL
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | 2.35× | ||
| Q3 24 | 1.52× | 9.94× | ||
| Q2 24 | 1.40× | 10.35× | ||
| Q1 24 | 1.15× | 2.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
BILL
| Accounts Payable And Accounts Receivable Solutions | $185.9M | 45% |
| Spend And Expense Interchange Revenue | $166.5M | 40% |
| Interest On Funds Held For Customers | $39.5M | 10% |
| Embedded And Other Solutions | $22.8M | 5% |
